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S A patient who had undergone subtotal 
ummary parathyroidectomy while on chronic 
hremodialysis became severely hypocalcremic after 
receiving a well-functioning cadaveric renal graft. 
After a homologous parathyroid implant, there was a 
biochemical improvement in the patient, and at biopsy 
6 months later the parathyroid graft was histologically 
normal. 21 months after the implant, serum calcium 
and phosphorus remain normal without calcium 
supplementation. 
Introduction 
ABOUT a hundred attempts at homologous para-
thyroid transplantation in man have been reported,l-a 
but with three possible exceptions there has been no 
histological proof of graft surviVal. Two of the three 
reports were published 50 years ago, and incon-
clusively described "remnants of three small glands 
which, although degenerated, had the histologic 
appearance of parathyroid tissues" 4 and "a nodule 
containing an array of aligned cells rather unusual in 
appearance, with an architecture revealing epithelial 
cell-like structures resembling parathyroid".' In 
the third instance, histologically intact homologous 
parathyroid tissue was found in a millipore chamber 
that had been implanted for 5 months, but the patient 
had demonstrated no biochemical or clinical improve-
ment." 
We report the morphological survival and apparent 
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patient who, unlike the earlier parathyroid-transplant 
recipients, was immunosuppressed. 
Case-report 
A 46-year-old male with polycystic kidney disease had 
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been on chronic hremodialysis since 1966. In 1969, skeletal 
pain, spontaneous rib fractures, and raised serum-calcium 
levels (11·5-12·2 mg. per 100 mi.) developed. Exploration 
of the neck in February, 1970, revealed parathyroid hyper-
plasia, and three and a half glands were removed. Post-
operatively, serum-calcium was within normal limits and 
the bone disease improved. 
After cadaveric renal transplantation at the Denver 
Veterans Administration Hospital on May 28, 1971, renal 
function became normal and rejection was never diagnosed 
(fig. 1). Postoperatively the patient was immunosuppressed 
with cyclophosphamide or azathioprine, prednisone, and 
antilymphocyte globulin (fig. 1). Other medications in-
cluded reserpine, hydrallazine hydrochloride, and chloro-
thiazide. The first 2 postoperative months were complicated 
by recurrent convulsive seizures, dysphasia, and dyskinesia. 
Neurological examination only showed arteriosclerotic 
vessels by cerebral angiography. Subsequently, the patient's 
neurological condition improved slowly and at present 
only moderate dysphasia remains. 
Immediately after the renal transplantation, serum-calcium 
dropped to subnormal levels (6-7·5 mg. per 100 mI.). 
Oral supplementation with calcium did not bring the serum 
levels to normal and calcium had to be administered intra-
venously (fig. 1). During this time, tubular reabsorption 
of phosphorus was 75 to 95%. . 
52 days after renal transplantation, four separate pieces 
of homologous hyperplastic parathyroid tissue (approxi-
mately 150 mg.) were implanted into the patient's pectoralis 
muscle. The grafts were obtained from another renal-
transplant recipient undergoing subtotal parathyroidectomy. 
The donor was blood-group A, while the recipient was of 
blood-group O. 
Initially, the recipient's serum-calcium remained below 
normal, necessitating further supplementation with calcium 
and vitamin D2 (fig. 1). But 2 months after implantation, 
all supplementation could be stopped. In January, 1972, 
a biopsy specimen was taken from the site of the parathyroid 
grafting. This was followed by a transient drop in serum-
calcium, and supplementary treatment was reinstituted 
for a few days (fig. 1). In the ensuing 12 months, serum 
calcium and phosphorus have been within normal limits. 
Results 
The parathyroid tissue used for implantation 
consisted microscopically of sheets of enlarged chief 
cells with occasional acini, characteristic of secondary 
hyperplasia. On biopsy 6 months after implantation, 
cords and clusters of chief cells were set in a fine, 
highly vascuIarised stroma characteristic of normal 
parathyroid tissue (fig. 2). Occasional interstitial 
collections of lymphocytes and plasma-cells suggested 
slight homograft rejection. Electron microscopy was 
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Fig. 2-Parathyroid tissue obtained at biopsy 6 months after 
homologous implantation. 
The glandular tissue is surrounded by skeletal muscle. Area 
shown is focally infiltrated by lymphocytes and plasma-cells 
(arrows); most of graft was without such cells. (Hrematoxylin and 
eosin. x 100.) 
performed on tissue which had been embedded in a 
paraffin block and was thus poorly preserved ultra-
structurally. However, large amounts of glycogen, 
occasional prominent arrays of rough endoplasmic 
reticulum, and secretion granules characteristic of 
functioning parathyroid cells 7 were apparent (fig. 3). 
Discussion 
The early assumption that homologous endocrine 
implants enjoy a major immunological privilege has 
never been substantiated. On the contrary, several 
experimental studies have shown that rejection of 
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thyroid-parathyroid grafts does occur."-lO 
Parathyroid grafting during immunosuppression 
has not previously been attempted in man. Our 
patient was receiving immunosuppressive drugs after 
renal transplantation. Immunosuppression was highly 
effective, as judged by the uninterrupted and excellent 
functioning of the kidney graft thereafter. Con-
sequently, it was not surprising that there was only 
slight evidence of rejection in the biopsy specimen of 
the parathyroid graft obtained after 6 months. 
Fig. 3-Parathyroid tissue obtained at biopsy 6 months -~DDDr 
homologous implantation. 
Granular endoplasmic reticulum (ER), glycogen (G), and 
secretory granules (arrows) are shown. ( x 21,000.) 
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There was strong biochemical evidence that hypo-
parathyroidism had developed after subtotal para-
thyroidectomy. When the artificial metabolic con-
ditions of chronic hremodialysis were followed by the 
normal renal function after transplantation, serum-
calcium fell to extremely low levels. At the same time, 
the fractional tubular reabsorption of phosphorus far 
exceeded that usually recorded in patients with good 
graft function who are being treated with steroids and 
thiazides.l1 
Recovery from surgically caused hypoparathyroidism 
has been reported after temporary administ.ration of 
vitamin D and may even occur " spontaneously". ,. 
However, it seems more likely that in the present 
patient the restoration of normal calcium homreo-
stasis was the consequence of hormone excretion 
from the graft. Indirect evidence for graft function 
was obtained from the electron-microscopic pictures 
of the biopsy specimen. The delay, in effect, could 
be attributed to the time required for revascularisation 
and healing of the free, grafted tissue. Efforts to 
measure parathormone levels in the stored sera from 
our patient gave results which were not reproducible 
and were consequently not as useful for following the 
postoperative course as were other serum levels 
which measured parathyroid function. 
Better techniques for the measurement of para-
thormone will be invaluable for assessing parathyroid-
homograft function. Parathyroid transplantation will 
probably be indicated in other recipients of renal 
homografts, since the removal of hyperplastic para-
thyroid glands to control bone disease is becoming 
more common. An accident to the residual glandular 
tissue could lead to the situation which developed in 
our recipient. Ironically, the best opportunities for 
obtaining a suitable homograft for such a patient will 
be provided by other members of the kidney-transplant 
population. 
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